PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ELV vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ELV and ABBV is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

ELV vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elevance Health Inc (ELV) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-29.71%
6.99%
ELV
ABBV

Key characteristics

Sharpe Ratio

ELV:

-0.82

ABBV:

0.86

Sortino Ratio

ELV:

-0.98

ABBV:

1.18

Omega Ratio

ELV:

0.86

ABBV:

1.19

Calmar Ratio

ELV:

-0.55

ABBV:

1.07

Martin Ratio

ELV:

-1.48

ABBV:

2.91

Ulcer Index

ELV:

12.85%

ABBV:

7.03%

Daily Std Dev

ELV:

23.30%

ABBV:

23.76%

Max Drawdown

ELV:

-67.19%

ABBV:

-45.09%

Current Drawdown

ELV:

-33.20%

ABBV:

-11.71%

Fundamentals

Market Cap

ELV:

$84.95B

ABBV:

$309.92B

EPS

ELV:

$27.47

ABBV:

$2.88

PE Ratio

ELV:

13.33

ABBV:

60.90

PEG Ratio

ELV:

0.68

ABBV:

0.42

Total Revenue (TTM)

ELV:

$174.02B

ABBV:

$55.53B

Gross Profit (TTM)

ELV:

$48.61B

ABBV:

$42.68B

EBITDA (TTM)

ELV:

$10.82B

ABBV:

$24.24B

Returns By Period

In the year-to-date period, ELV achieves a -19.85% return, which is significantly lower than ABBV's 20.40% return. Over the past 10 years, ELV has underperformed ABBV with an annualized return of 12.98%, while ABBV has yielded a comparatively higher 15.09% annualized return.


ELV

YTD

-19.85%

1M

-6.98%

6M

-29.83%

1Y

-19.00%

5Y*

5.43%

10Y*

12.98%

ABBV

YTD

20.40%

1M

1.72%

6M

7.24%

1Y

20.43%

5Y*

20.00%

10Y*

15.09%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ELV vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Elevance Health Inc (ELV) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ELV, currently valued at -0.82, compared to the broader market-4.00-2.000.002.00-0.820.86
The chart of Sortino ratio for ELV, currently valued at -0.98, compared to the broader market-4.00-2.000.002.004.00-0.981.18
The chart of Omega ratio for ELV, currently valued at 0.86, compared to the broader market0.501.001.502.000.861.19
The chart of Calmar ratio for ELV, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.551.07
The chart of Martin ratio for ELV, currently valued at -1.48, compared to the broader market0.0010.0020.00-1.482.91
ELV
ABBV

The current ELV Sharpe Ratio is -0.82, which is lower than the ABBV Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of ELV and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.82
0.86
ELV
ABBV

Dividends

ELV vs. ABBV - Dividend Comparison

ELV's dividend yield for the trailing twelve months is around 1.75%, less than ABBV's 3.44% yield.


TTM20232022202120202019201820172016201520142013
ELV
Elevance Health Inc
1.75%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%1.39%1.62%
ABBV
AbbVie Inc.
3.44%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

Drawdowns

ELV vs. ABBV - Drawdown Comparison

The maximum ELV drawdown since its inception was -67.19%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ELV and ABBV. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-33.20%
-11.71%
ELV
ABBV

Volatility

ELV vs. ABBV - Volatility Comparison

Elevance Health Inc (ELV) has a higher volatility of 7.01% compared to AbbVie Inc. (ABBV) at 5.89%. This indicates that ELV's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
7.01%
5.89%
ELV
ABBV

Financials

ELV vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Elevance Health Inc and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab